Table 2 Patient characteristics and pMMA and uMMA values of a subset of individuals from the MARLINA trial. Number of samples in each group and subgroup.

From: Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans

Groups

Plasma

Urine

Total

301

245

White

60

60

Asian

183

183

Other/Unknown

58

2

Linagliptin

151

120

Placebo

150

125